225 related articles for article (PubMed ID: 7959407)
1. [Serotonin (5-HT)3 receptors: antagonists and their pharmacological profiles].
Miyata K; Honda K
Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):143-52. PubMed ID: 7959407
[TBL] [Abstract][Full Text] [Related]
2. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
Miyata K; Yamano M; Kamato T; Akuzawa S
Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Gregory RE; Ettinger DS
Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats.
Yamano M; Ito H; Kamato T; Miyata K
Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
Ito H; Akuzawa S; Tsutsumi R; Kiso T; Kamato T; Nishida A; Yamano M; Miyata K
Neuropharmacology; 1995 Jun; 34(6):631-7. PubMed ID: 7566499
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H
Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388
[TBL] [Abstract][Full Text] [Related]
7. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
[TBL] [Abstract][Full Text] [Related]
8. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
Yamano M; Ito H; Kamato T; Miyata K
Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F
J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119
[TBL] [Abstract][Full Text] [Related]
10. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
11. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications.
Talley NJ
Aliment Pharmacol Ther; 1992 Jun; 6(3):273-89. PubMed ID: 1600046
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of use and tolerability of 5-HT3 receptor antagonists.
Haus U; Späth M; Färber L
Scand J Rheumatol Suppl; 2004; 119():12-8. PubMed ID: 15515406
[TBL] [Abstract][Full Text] [Related]
13. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
[TBL] [Abstract][Full Text] [Related]
14. [Serotonin and anticancer drug-induced emesis].
Minami M; Endo T; Hamaue N; Hirafuji M
Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
16. Serotonin exerts a direct modulatory role on bladder afferent firing in mice.
Konthapakdee N; Grundy L; O'Donnell T; Garcia-Caraballo S; Brierley SM; Grundy D; Daly DM
J Physiol; 2019 Nov; 597(21):5247-5264. PubMed ID: 31520534
[TBL] [Abstract][Full Text] [Related]
17. Recent advances with 5-HT
Juza R; Vlcek P; Mezeiova E; Musilek K; Soukup O; Korabecny J
Med Res Rev; 2020 Sep; 40(5):1593-1678. PubMed ID: 32115745
[TBL] [Abstract][Full Text] [Related]
18. Investigation of 5-HT3 receptor-mediated contraction in guinea-pig distal colon.
Yamano M; Miyata K
Eur J Pharmacol; 1996 Dec; 317(2-3):353-9. PubMed ID: 8997621
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis.
Tonini M; Candura SM; Messori E; Rizzi CA
Pharmacol Res; 1995 May; 31(5):257-60. PubMed ID: 7479521
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
